Tri-Lustra Indications/Uses

TRI-Lustra Cream is indicated for the short-term treatment of moderate to severe melasma of the face, in the presence of measures for sun avoidance, including the use of sunscreens.
The following are important statements relating to the indication and usage of TRI-Lustra Cream: TRI-Lustra Cream, a combination drug product containing corticosteroid, retinoid, and bleaching agent, was proven safe for the intermittent treatment of melasma with cumulative treatment time of at least 180 days. Because melasma usually recurs upon discontinuation of TRI-Lustra Cream, patients need to avoid sunlight exposure, use sunscreen with appropriate SPF, wear protective clothing, and change to non-hormonal forms of birth control, if hormonal methods are used.
The safety and efficacy of TRI-Lustra Cream in patients of skin types V and VI have not been studied. Excessive bleaching resulting in undesirable cosmetic effect in patients with darker skin cannot be excluded.
The safety and efficacy of TRI-Lustra Cream in the treatment of hyperpigmentation conditions other than melasma of the face have not been studied.
Because pregnant and lactating women were excluded from, and women of child-bearing potential had to use birth control measures in the clinical trials, the safety and efficacy of TRI-Lustra Cream in pregnant women and nursing mothers have not been established.